Spectral Tissue Recognition for Breast Cancer Surgery
Part of Cancer, Skin clinical trials.
This trial is testing a new way to identify cancer tissue during breast surgery. It may help surgeons remove cancer more completely during a lumpectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with breast cancer and need surgery.
- Your surgery is planned to be a lumpectomy (breast-conserving surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
This trial tests a new imaging method to help doctors see if any cancer cells are left at the edges of removed tissue during breast cancer surgery. It may reduce the need for follow-up surgeries.
This study tests a device called LumiSystem that helps doctors check if all cancer cells are removed during breast cancer surgery. The goal is to see if using it improves surgery outcomes.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
Hear when a new Margin Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.